化合物、組成物および方法 - Cytokinetics Incorporated

Title:

化合物、組成物および方法

Document Type and Number:

Japanese Patent JP2006502230

Kind Code:

A

Abstract:

1,2,4-Triazin-5-ones useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.

More Like This:

JP3439211	INDUSTRIAL APPLICABILITY The use of 3,5-diamino-6- (2,3-dichlorophenyl) -1,2,4-triazine isethionate in the treatment and prevention of drug dependence, tolerance and sensitization.
JP2001526275	INDUSTRIAL APPLICABILITY [Title of Invention] A triazine compound for the treatment of central nervous system disorders.
JP2002508001	INDUSTRIAL APPLICABILITY: 6-Azauracil derivative as an IL-5 inhibitor

Inventors:

Kian, Champin
Bergnes, Gustave
Morgans, David, Jay., Junior

Application Number:

JP2004543727A

Publication Date:

January 19, 2006

Filing Date:

October 09, 2003

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Cytokinetics Incorporated

International Classes:

C07D253/06; A61K31/53; A61K31/551; A61P9/00; A61P17/06; A61P29/00; A61P35/00; A61P37/00; C07D253/07; C07D403/06

Attorney, Agent or Firm:

Yusuke Hiraki
Ishii Teiji
Satoshi Fujita

Previous Patent: JP2006502229

Next Patent: 大量失血を被っている患者の処置方法